Cargando…
Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?
BACKGROUND: Polycystic ovary syndrome (PCOS) is considered a risk factor for the development of type 2 diabetes mellitus (T2DM). However, which is the most appropriate way to evaluate dysglycemia in women with PCOS and who are at increased risk are as yet unclear. AIM OF THE STUDY: To determine the...
Autores principales: | Livadas, Sarantis, Bothou, Christina, Kuliczkowska-Płaksej, Justyna, Robeva, Ralitsa, Vryonidou, Andromahi, Macut, Jelica Bjekic, Androulakis, Ioannis, Opalic, Milica, Mouslech, Zadalla, Milewicz, Andrej, Gambineri, Alessandra, Panidis, Dimitrios, Macut, Djuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066574/ https://www.ncbi.nlm.nih.gov/pubmed/35258478 http://dx.doi.org/10.1530/EC-21-0358 |
Ejemplares similares
-
MON-030 Intermediate Hyperglycemia and Type 2 Diabetes in Women with Polycystic Ovary Syndrome: Findings from Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2020) -
MON-214 The Natural Course of Normal Weight Women with Polycystic Ovary Syndrome: An Insight into Metabolic Changes of Large Caucasian Cohort
por: Livadas, Sarantis, et al.
Publicado: (2019) -
Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome
por: Livadas, Sarantis, et al.
Publicado: (2023) -
Metabolic Perspectives for Non-classical Congenital Adrenal Hyperplasia With Relation to the Classical Form of the Disease
por: Macut, Djuro, et al.
Publicado: (2019) -
Editorial: Congenital Adrenal Hyperplasia, Unresolved Issues and Implications on Clinical Management
por: Livadas, Sarantis, et al.
Publicado: (2020)